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Increasing evidence suggests that mitoNEET, a target of the
type II diabetes drug pioglitazone, is a key regulator of energy
metabolism in mitochondria. MitoNEET is anchored to the
mitochondrial outer membrane via its N-terminal ␣ helix
domain and hosts a redox-active [2Fe-2S] cluster in its C-terminal cytosolic region. The mechanism by which mitoNEET regulates energy metabolism in mitochondria, however, is not fully
understood. Previous studies have shown that mitoNEET specifically interacts with the reduced flavin mononucleotide
(FMNH2) and that FMNH2 can quickly reduce the mitoNEET
[2Fe-2S] clusters. Here we report that the reduced mitoNEET
[2Fe-2S] clusters can be readily oxidized by oxygen. In the presence of FMN, NADH, and flavin reductase, which reduces FMN
to FMNH2 using NADH as the electron donor, mitoNEET mediates oxidation of NADH with a concomitant reduction of oxygen. Ubiquinone-2, an analog of ubiquinone-10, can also oxidize
the reduced mitoNEET [2Fe-2S] clusters under anaerobic or
aerobic conditions. Compared with oxygen, ubiquinone-2 is
more efficient in oxidizing the mitoNEET [2Fe-2S] clusters, suggesting that ubiquinone could be an intrinsic electron acceptor
of the reduced mitoNEET [2Fe-2S] clusters in mitochondria.
Pioglitazone or its analog NL-1 appears to inhibit the electron
transfer activity of mitoNEET by forming a unique complex with
mitoNEET and FMNH2. The results suggest that mitoNEET is a
redox enzyme that may promote oxidation of NADH to facilitate
enhanced glycolysis in the cytosol and that pioglitazone may
regulate energy metabolism in mitochondria by inhibiting the
electron transfer activity of mitoNEET.

Pioglitazone is a drug prescribed for the treatment of type II
diabetes (1). In addition to acting on peroxisome proliferatoractivated receptor ␥ (PPAR␥), which regulates the expression
of genes related to insulin sensitivity (2), pioglitazone also has a
rapid pharmacological effect on energy metabolism in mitochondria (3). A search of pioglitazone-binding targets revealed
a new protein, mitoNEET, that localizes in the mitochondrial
outer membrane (4). In mice, deletion of mitoNEET results in a
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decrease in oxidative phosphorylation capacity in mitochondria by about 30% (5). On the other hand, overexpression of
mitoNEET enhances lipid storage and decreases oxidative
damage in adipocytes (6, 7) and inhibits ferroptosis in human
hepatocellular carcinoma cells (8). In ␤ cells, increased expression of mitoNEET leads to hyperglycemia and glucose intolerance (9). In spinal neurons, microRNA-127 has been shown to
specifically target the expression of mitoNEET, and depletion
of mitoNEET results in neuronal loss and apoptosis (10). In
breast cancer cells, mitoNEET is highly expressed, and depletion of mitoNEET inhibits cancer cell proliferation (11, 12). It
has thus been postulated that mitoNEET is a key regulator
of energy metabolism in mitochondria (13) and an attractive
chemotherapeutic target for treating mitochondrion-related
human diseases (14 –17).
Crystallographic studies have shown that mitoNEET is a
homodimer, with each monomer hosting a [2Fe-2S] cluster via
an unusual ligand arrangement of three cysteine residues and
one histidine residue in its C-terminal cytosolic domain (18 –
21). The N terminus of mitoNEET has a transmembrane ␣ helix
that anchors the protein to the mitochondrial outer membrane
(4). However, the mechanism by which mitoNEET regulates
energy metabolism in mitochondria still remains elusive. One
hypothesis states that mitoNEET may transfer its [2Fe-2S] clusters to apo-proteins such as apo-ferredoxin (22), iron regulatory protein-1 (IRP-1) (23), or anamorsin, a protein required for
iron-sulfur cluster assembly in cytosol (24). Because mitochondria are the primary sites for iron-sulfur cluster biogenesis in
cells (25), it is tempting to propose that mitoNEET is a carrier
transporting the clusters assembled in mitochondria to target
proteins in the cytosol (22–24). However, the observed cluster
transfer occurs only when the mitoNEET [2Fe-2S] clusters are
oxidized (22, 23), and the mitoNEET [2Fe-2S] clusters are
mostly in a reduced state in cells under normal physiological
conditions (26 –29). Thus, the exact role of mitoNEET in
iron-sulfur cluster biogenesis has yet to be further defined. An
alternative hypothesis is that mitoNEET may regulate mitochondrial functions via protein-protein interactions. This
hypothesis is based on the observations that mitoNEET interacts with mitochondrial proteins, including the Parkinson’s disease-associated protein Parkin (9), mitochondrial outer membrane import complex protein 1 (MTX1) (30), glutathione
reductase (28), and glutamate dehydrogenase 1 (31). Nevertheless, no direct evidence is available suggesting that the function
of mitochondrial proteins are regulated by mitoNEET.
J. Biol. Chem. (2017) 292(24) 10061–10067
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Results
Reduction of the mitoNEET [2Fe-2S] clusters under anaerobic
and aerobic conditions
Previous studies have shown that human mitoNEET has a
specific interaction with FMNH2 and that FMNH2 can
quickly reduce the mitoNEET [2Fe-2S] clusters (29). As oxygen would be present in mitochondria, we asked whether
oxygen will have any effects on the FMNH2-mediated reduction of the mitoNEET [2Fe-2S] clusters.
To test this idea, human mitoNEET was preincubated with
FMN and NADH under anaerobic or aerobic conditions. The
reaction was initiated by adding a catalytic amount of Escherichia coli flavin reductase (32) to reduce FMN using NADH as
the electron donor (29). Fig. 1A shows that, under anaerobic
conditions, the oxidized mitoNEET [2Fe-2S] clusters (indicated by the absorption peaks at 455 nm and 540 nm (27)) were
quickly reduced upon addition of flavin reductase, as reported
previously (29). About 10 M NADH was oxidized when 10 M
mitoNEET [2Fe-2S] clusters were reduced in the incubation
solution under anaerobic conditions (Fig. 1C). Under aerobic
conditions, the mitoNEET [2Fe-2S] clusters were also fully
reduced after addition of flavin reductase (Fig. 1B). However,
NADH was continuously oxidized even after the mitoNEET
[2Fe-2S] clusters were fully reduced (Fig. 1C). The observed
oxidation of NADH was mitoNEET-dependent, as only a very
small amount of NADH was oxidized in the same incubation
solution without mitoNEET under aerobic conditions (Fig.
1D). Thus, mitoNEET is able to promote oxidation of NADH
in the presence of flavin reductase and FMN under aerobic
conditions.
The reduced mitoNEET [2Fe-2S] clusters are oxidized by
oxygen under aerobic conditions
In the presence of flavin reductase, FMN and excess NADH,
the mitoNEET [2Fe-2S] clusters were fully reduced under aerobic conditions (Fig. 1B). One explanation could be that the
reduced mitoNEET [2Fe-2S] clusters are oxidized by oxygen
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In previous studies, we have found that human mitoNEET
has a specific interaction with the reduced flavin mononucleotide (FMNH2) and that FMNH2 can rapidly reduce the
mitoNEET [2Fe-2S] clusters (29). Here we report that the
reduced mitoNEET [2Fe-2S] clusters can be oxidized by oxygen
or ubiquinone-2. Compared with oxygen, ubiquinone-2
appears to be more efficient in oxidizing the mitoNEET [2Fe2S] clusters, indicating that ubiquinone may act as a native electron acceptor of the reduced mitoNEET [2Fe-2S] clusters in
mitochondria. In the presence of flavin reductase, which
reduces FMN to FMNH2 using NADH as the electron donor,
mitoNEET mediates oxidation of NADH with a concomitant
reduction of oxygen or ubiquinone-2. Furthermore, pioglitazone can effectively inhibit the electron transfer activity of
mitoNEET by forming a unique complex with mitoNEET and
FMNH2. The results led us to propose that mitoNEET is a redox
enzyme that may promote oxidation of NADH to enhance glycolysis in the cytosol and that pioglitazone may regulate energy
metabolism in mitochondria by inhibiting the electron transfer
activity of mitoNEET.
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Figure 1. Reduction of the mitoNEET [2Fe-2S] clusters by FMNH2 under
aerobic and anaerobic conditions. A and B, MitoNEET (containing 10 M
[2Fe-2S] clusters) was incubated with FMN (0.1 M) and NADH (60 M) under
anaerobic (A) and aerobic (B) conditions. Fre (0.1 M) was then added to the
solutions to initiate the reaction. UV-visible absorption spectra were taken
every 80 s after addition of Fre for 560 s. Absorption peaks at 455 nm and 540
nm represent the oxidized mitoNEET [2Fe-2S] clusters. O.D., optical density. C,
time courses of NADH oxidation in the incubation solutions containing
mitoNEET, Fre, and FMN under anaerobic (closed circles) or aerobic (open circles) conditions. The amount of NADH in the incubation solutions was measured from the absorption peak at 340 nm after subtracting the absorption of
proteins in the incubation solutions. D, the same as in B, except no mitoNEET
was included. The data are representative of three independent experiments.

and rapidly rereduced by FMNH2/NADH/flavin reductase
under aerobic conditions.
To test this idea, mitoNEET was incubated with a limited
amount of NADH and FMN under aerobic conditions. As
shown in Fig. 2, the mitoNEET [2Fe-2S] clusters were fully
reduced upon addition of a catalytic amount of flavin reductase.
However, when NADH in the incubation solution was completely oxidized, the reduced mitoNEET [2Fe-2S] clusters were
gradually reoxidized under aerobic conditions, demonstrating
that the reduced mitoNEET [2Fe-2S] clusters are indeed oxidized by oxygen under aerobic conditions.
The reduced mitoNEET [2Fe-2S] clusters can also be oxidized
by ubiquinone-2 under anaerobic conditions
In mitochondria, NADH-ubiquinone oxidoreductase (complex I) oxidizes NADH and reduces ubiquinone via FMN and a
chain of iron-sulfur clusters (33). Ubiquinone is a key electron
transport component in the respiratory chain (34) and is present in both the mitochondrial inner and outer membranes (35).
As mitoNEET is a mitochondrial outer membrane protein (4),
and the [2Fe-2S] clusters in mitoNEET are positioned close
to the membrane (18 –21), we postulated that the reduced
mitoNEET [2Fe-2S] clusters may also reduce ubiquinone in the
mitochondrial outer membrane.
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Figure 2. Oxidation kinetics of the reduced mitoNEET [2Fe-2S] clusters
by oxygen. MitoNEET (containing 10 M [2Fe-2S] clusters) was incubated
with FMN (0.1 M) and NADH (20 M) under aerobic conditions. Fre (0.1 M)
was then added to the incubation solution to initiate the reaction. The
amount of NADH in the incubation solution was measured from the absorption peak at 340 nm. The amount of the reduced mitoNEET [2Fe-2S] clusters
was measured from the different absorption at absorption peaks of 455 nm
and 420 nm. The amounts of NADH and the reduced mitoNEET [2Fe-2S] clusters in the incubation solution were plotted as a function of incubation time.
The data are representative of three independent experiments.

In the experiments, the mitoNEET [2Fe-2S] clusters were
prereduced with flavin reductase, FMN, and an excess amount
of NADH under anaerobic conditions. Ubiquinone-2, a ubiquinone-10 analog, was then injected into the incubation solution
anaerobically using a gas-tight syringe. Fig. 3 shows that the
reduced mitoNEET [2Fe-2S] clusters were immediately oxidized upon injection of ubiquinone-2 under anaerobic conditions. As a control, injection of degassed water had no effect on
the reduced mitoNEET [2Fe-2S] clusters (data not shown).
After further incubation, the ubiquinone-2-oxidized mitoNEET
[2Fe-2S] clusters were fully rereduced in the incubation solution (Fig. 3A), suggesting that oxidation of the mitoNEET [2Fe2S] clusters by ubiquinone-2 is reversible.
We also tested whether the reduced mitoNEET [2Fe-2S]
clusters could be oxidized by other oxidants. In the experiments, the mitoNEET [2Fe-2S] clusters were prereduced with
flavin reductase, FMN, and an excess amount of NADH under
anaerobic conditions, followed by injection of oxidants anaerobically. We found that dichloroindophenol, K3Fe(CN)6, or
menadione could all quickly oxidize the reduced mitoNEET
[2Fe-2S] clusters (supplemental Fig. 1), suggesting that the
reduced mitoNEET [2Fe-2S] clusters may also be oxidized by
other oxidants in the cytosol. Oxidation of the mitoNEET [2Fe2S] clusters by dichloroindophenol or K3Fe(CN)6 was very similar to that of ubiquinone-2. However, menadione appeared to
be less active to oxidize the mitoNEET [2Fe-2S] clusters under
the experimental conditions (supplemental Fig. 1). Because
ubiquinone is a physiological oxidant and is in the vicinity of the
mitoNEET [2Fe-2S] clusters in mitochondria, we propose that
ubiquinone could be a native electron acceptor for the reduced
mitoNEET [2Fe-2S] clusters in mitochondria.
Oxidation of the reduced mitoNEET [2Fe-2S] clusters by
ubiquinone-2 under aerobic conditions
Compared with oxygen (Fig. 2), ubiquinone-2 is much more
efficient in oxidizing the reduced mitoNEET [2Fe-2S] clusters
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Figure 3. Oxidation of the reduced mitoNEET [2Fe-2S] clusters by ubiquinone-2 under anaerobic condition. A, oxidation of the reduced mitoNEET
[2Fe-2S] clusters by ubiquinone-2 under anaerobic conditions. MitoNEET
(containing 10 M [2Fe-2S] clusters) was reduced with FMN (0.1 M) and
NADH (50 M) and flavin reductase (0.1 M) under anaerobic conditions.
Ubiquinone-2 (Q2, 20 M) was injected into the incubation solution anaerobically as indicated. The reduced mitoNEET [2Fe-2S] clusters were measured
from the different absorption at absorption peaks of 455 nm and 420 nm and
plotted as a function of the incubation time. B, UV-visible absorption spectra
of mitoNEET. Spectra were taken before (spectrum 1) and after (spectrum 2)
addition of NADH (50 M). Spectrum 3, right after anaerobic addition of
ubiquinone-2 (20 M). The experiments were repeated three times. Similar
results were obtained. O.D., optical density.

(Fig. 3A). To further explore the reactivity of the reduced
mitoNEET [2Fe-2S] clusters with oxygen and ubiquinone-2, we
incubated mitoNEET with FMN, NADH, and ubiquinone-2
under aerobic conditions. Fig. 4A shows that NADH was continuously oxidized after flavin reductase was added to the incubation solution. The observed NADH oxidation was mitoNEETdependent, as only a very small amount of NADH was oxidized
in the incubation solution without mitoNEET under aerobic
conditions (Fig. 4B). Importantly, despite oxidation of NADH
in the incubation solution containing ubiquinone-2, the
mitoNEET [2Fe-2S] clusters remained oxidized during the
incubation process (Fig. 4A). This result indicates that
the reduced mitoNEET [2Fe-2S] clusters might be rapidly oxidized by ubiquinone-2, which subsequently transfers electron
to oxygen under aerobic conditions. Indeed, when the incubation solution in Fig. 4A was purged with pure argon gas to
remove oxygen, the mitoNEET [2Fe-2S] clusters were rereduced upon addition of NADH (Fig. 4, C and D). Thus, the
results further suggest that ubiquinone in mitochondria may
act as an intrinsic electron acceptor for the mitoNEET [2Fe-2S]
clusters under anaerobic or aerobic conditions.
A pioglitazone analog, NL-1, inhibits the electron transfer
activity of mitoNEET
MitoNEET was identified as a target of the type II diabetes
drug pioglitazone (1). However, pioglitazone has a very low solubility in water (⬍1 mg/ml), making it difficult to characterize
its biochemical activity (28). A new pioglitazone analog, NL-1
or
5-(3,5-di-tert-butyl-4-hydroxybenzyl)-4-hydroxythiazol2(5H)-one, was designed and synthesized by Geldenhuys et al.
(36). NL-1 has been improved for its solubility in water and
binding specificity to mitoNEET. It has similar pharmacological activities as pioglitazone to decrease the maximal respiration rate of mitochondria by 45%, reduce the production of
reactive oxygen species (36), and improve the survival of cardiac stem cells during oxidative stress (37).
J. Biol. Chem. (2017) 292(24) 10061–10067
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Figure 5. Inhibition of the electron transfer activity of mitoNEET by the
pioglitazone analog NL-1. MitoNEET (containing 10 M [2Fe-2S] clusters)
was preincubated with increasing concentrations of NL-1 (from 0 –250 M) at
room temperature for 30 min under aerobic conditions, followed by addition
of FMN (0.1 M) and flavin reductase (0.1 M). NADH (50 M) was then added
to the incubation solutions to initiate the reaction. The amount of the
reduced mitoNEET [2Fe-2S] clusters in the incubation solutions was measured from the different absorption at absorption peaks of 455 nm and 420
nm and plotted as function of the reaction time after injection of NADH. The
data are representative of three independent experiments.
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Figure 4. Oxidation of the reduced mitoNEET [2Fe-2S] clusters by ubiquinone-2 under aerobic condition. A, mitoNEET (containing 10 M [2Fe-2S]
clusters) was preincubated with FMN (0.1 M), NADH (50 M), and ubiquinone-2 (20 M) under aerobic conditions. UV-visible absorption spectra were
taken every 40 s after addition of Fre (0.1 M) for 320 s. The amount of NADH
in the incubation solution was measured from the absorption peak at 340 nm.
O.D., optical density. B, the same as A, except mitoNEET was not included in
the incubation solution. C, the incubation solution in A was purged with pure
argon gas for 10 min, followed by injection of NADH (50 M) anaerobically.
UV-visible absorption spectra were taken every 40 s for 320 s. D, redox transition of the mitoNEET [2Fe-2S] clusters under aerobic and anaerobic conditions. The data are from A and C. The amount of the reduced mitoNEET [2Fe2S] clusters was measured from the different absorption at peaks of 455 nm
and 420 nm in each spectrum. The data are representative of three independent experiments.

Here we explored the effect of NL-1 on the electron transfer
activity of mitoNEET. In the experiments, mitoNEET was preincubated with increasing concentrations of NL-1 under aerobic conditions, followed by addition of flavin reductase and
FMN. The reaction was initiated by adding NADH. The
amounts of the reduced mitoNEET [2Fe-2S] clusters in the
incubation solutions were monitored spectroscopically and
plotted as a function of incubation time. Fig. 5 shows that, as
the concentration of NL-1 increased, the reduction of the
mitoNEET [2Fe-2S] clusters in the incubation solution gradually decreased. At 250 M NL-1, the reduction of the mitoNEET
[2Fe-2S] clusters (10 M) in the incubation solution was inhibited by about 70%, indicating that NL-1 can effectively block the
electron transfer activity of mitoNEET.
Pioglitazone/NL-1 and FMNH2 forms a unique complex with
the reduced mitoNEET [2Fe-2S] clusters
To further assess the effects of pioglitazone and its analog
NL-1 on the electron transfer activity of mitoNEET, mitoNEET
was incubated with FMN, pioglitazone, NL-1, or combinations
at room temperature for 1 h under aerobic conditions. The
samples were then reduced with sodium dithionite for electron
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paramagnetic resonance (EPR)2 measurements of the reduced
mitoNEET [2Fe-2S] clusters. Fig. 6A shows that incubation
with FMNH2 results in a small EPR signal at g ⫽ 1.85 of the
reduced mitoNEET [2Fe-2S] clusters (spectrum 2), as reported
previously (29). However, unlike FMNH2, incubation with
pioglitazone (4) (Fig. 6A, spectrum 3) or NL-1 (36) (Fig. 6A,
spectrum 4) did not change the EPR spectrum of the reduced
mitoNEET [2Fe-2S] clusters. Nevertheless, incubation of
mitoNEET with FMNH2 and pioglitazone completely shifted
the typical EPR spectrum at g ⫽ 1.94 of the reduced mitoNEET
[2Fe-2S] clusters to a new EPR spectrum with g ⫽ 1.85 (Fig. 6A,
spectrum 5). The same result was also observed when
mitoNEET was incubated with FMNH2 and NL-1 (Fig. 6A,
spectrum 6). While a small EPR signal at g ⫽ 1.86 of the reduced
mitoNEET [2Fe-2S] clusters was noticed previously (38), the
interpretation of the EPR signal at g ⫽ 1.85 remains elusive.
Nevertheless, the dramatic change of the EPR spectrum
strongly suggests that FMNH2 and pioglitazone/NL-1 may
have a close interaction with the reduced [2Fe-2S] clusters in
mitoNEET or that binding of FMNH2 and pioglitazone/NL-1
may result in conformational changes that alter the structural
orientation of the cluster ligands in mitoNEET.
MitoNEET was further incubated with a fixed concentration
of FMN and increasing concentrations of NL-1 at room temperature for 1 h under aerobic conditions, followed by reduction with sodium dithionite. Fig. 6B shows that, as the concentration of NL-1 increased, the EPR signal at g ⫽ 1.85 gradually
increased. About 200 M NL-1 was sufficient to change the EPR
spectrum of g ⫽ 1.94 to that of g ⫽ 1.85 of the reduced
mitoNEET [2Fe-2S] clusters. The results suggest that FMNH2
and pioglitazone/NL-1 have a synergistic effect on the reduced
mitoNEET [2Fe-2S] clusters.

2

The abbreviations used are: EPR, electron paramagnetic resonance; Fre, flavin reductase; g, the g-factor of an unpaired electron.
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Figure 6. Synergistic effect of FMNH2 and pioglitazone/NL-1 on the
reduced mitoNEET [2Fe-2S] clusters. A, EPR spectra of the reduced
mitoNEET [2Fe-2S] clusters. MitoNEET (containing 20 M [2Fe-2S] clusters,
spectrum 1) was incubated with FMN (50 M, spectrum 2), pioglitazone (Pio,
500 M, spectrum 3), NL-1 (200 M, spectrum 4), FMN ⫹ pioglitazone (spectrum
5), and FMN ⫹ NL-1 (spectrum 6) at room temperature for 60 min. After incubation, samples were reduced with freshly prepared sodium dithionite (4
mM), transferred to EPR tubes, and immediately frozen in liquid nitrogen for
EPR measurements. mT, millitesla. B, titration of NL-1. MitoNEET (containing
20 M [2Fe-2S] clusters) was incubated with FMN (50 M) and increasing concentrations of NL-1 (0 to 200 M) (spectra 1–5) at room temperature for 60 min.
After incubation, samples were reduced with freshly prepared sodium dithionite (4 mM), transferred to EPR tubes, and immediately frozen in liquid nitrogen for EPR measurements. The data are representative of three independent
experiments.

Discussion
MitoNEET is a founding member of a small family of proteins that contain a CDGSH motif (39, 40). Although it has been
reported that mitoNEET is a key regulator of energy metabolism in mitochondria (13), the underlying mechanism has not
been fully understood. Several research groups proposed that
mitoNEET may transfer its [2Fe-2S] clusters for maturation of
iron-sulfur proteins in the cytosol (22–24). Others suggested
that mitoNEET may regulate mitochondrial functions via specific protein-protein interactions (9). Here we report that
mitoNEET is a novel redox enzyme that transfers electron from
FMNH2 to oxygen or ubiquinone in the mitochondrial outer
membrane via its [2Fe-2S] clusters. In this process, FMNH2,
which may be reduced by flavin reductase (41) and NADH in
the cytosol, binds to mitoNEET and reduces the [2Fe-2S] clusters in mitoNEET (29). The reduced mitoNEET [2Fe-2S] clusters are readily oxidized by oxygen or ubiquinone (Fig. 7).
Together with flavin reductase (41) and FMN, mitoNEET may
effectively promote oxidation of NADH in the cytosol with a
concomitant reduction of oxygen or ubiquinone in the mitochondrial outer membrane.
The intracellular concentration of FMN in human cells is in
the nanomolar range (42). Here we found that 100 nM FMN is
sufficient to reduce 10 M mitoNEET [2Fe-2S] clusters in the
presence of flavin reductase and NADH in less than 2 min (Fig.
1), indicating that FMN may act as an electron shuttle, reducing
the mitoNEET [2Fe-2S] clusters (29). In the cytosol, FMN is
reduced to FMNH2 by flavin reductase (41), using NADH as the
electron donor. Because glycolysis will produce NADH, which
must be oxidized to sustain glycolysis activity (43), mitoNEET

O2
Q

Figure 7. A proposed model for the electron transfer of mitoNEET in the
mitochondria outer membrane. In the cytosol, FMNH2 is reduced by flavin
reductase, using NADH as the electron donor. FMNH2 then reduces the
mitoNEET [2Fe-2S] clusters, which, in turn, transfer electrons to oxygen or
ubiquinone in the mitochondrial outer membrane. Together with flavin
reductase and FMN, mitoNEET promotes NADH oxidation with a concomitant
reduction of oxygen or ubiquinone in mitochondria.

may enhance glycolysis by promoting oxidation of NADH in
the cytosol (Fig. 7). In primary and metastatic cancer cells, glycolysis is highly up-regulated, resulting in increased glucose
consumption (44). Interestingly, mitoNEET is also highly
expressed in cancer cells, and overexpression of mitoNEET is
essential for cancer cell proliferation (11, 12). In this context, we
propose that overproduced mitoNEET may enhance glycolysis
in the cytosol by promoting oxidation of NADH in cancer cells.
Accordingly, when mitoNEET is deleted, oxidation of NADH
in the cytosol could be diminished, leading to a decrease in
glycolysis in the cytosol and oxidative phosphorylation in mitochondria. This notion is consistent with a previous report
showingthatdeletionofmitoNEETdecreasestheoxidativephosphorylation capacity in mitochondria by about 30% (5) and
inhibits cancer cell proliferation (11, 12). Nevertheless, additional experiments are required to elucidate the physiological
link between the electron transfer activity of mitoNEET and
glycolysis in cells.
Iron-sulfur clusters in proteins are often sensitive to oxygen
and reactive oxygen species (45). However, the mitoNEET
[2Fe-2S] clusters are highly resistant to oxygen and hydrogen
peroxide (27). In fact, the reduced mitoNEET [2Fe-2S] clusters
can be oxidized by oxygen without disruption of the cluster
(Fig. 2). Importantly, compared with oxygen, ubiquinone-2 is
more efficient in oxidizing the reduced mitoNEET [2Fe-2S]
clusters (Figs. 3 and 4). Because mitoNEET is a mitochondrial
outer membrane protein (4), and the [2Fe-2S] clusters in
mitoNEET are positioned close to the membrane (18 –21), we
propose that ubiquinone could be an intrinsic electron acceptor
for the reduced mitoNEET [2Fe-2S] clusters (Fig. 7). Upon the
single-electron reduction by the reduced mitoNEET [2Fe-2S]
cluster, ubiquinone is converted to semiquinone, which may be
further reduced to ubihydroquinone, or transfer the electron
to oxygen to produce superoxide or hydrogen peroxide (34).
Although other oxidants in the cytosol may also oxidize the
reduced mitoNEET [2Fe-2S] clusters in the cytosol, the proposed electron transfer path from NADH to ubiquinone catalyzed by the mitoNEET [2Fe-2S] clusters (Fig. 7) is reminiscent
of the electron transfer path in complex I, in which electrons in
NADH are transferred to ubiquinone via FMN and a chain of
iron-sulfur clusters (33). The observed reduction of oxygen by
the mitoNEET [2Fe-2S] clusters may reflect the possible electron transfer leak in mitoNEET, as reported in complex I (33).
The final products of the electron transfer reaction catalyzed by
mitoNEET in mitochondria remain to be determined.
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Pioglitazone has two major targets in cells: peroxisome proliferator-activated receptor ␥, which regulates the expression of
genes involved in insulin sensitivity (2), and mitoNEET (4),
which modulates energy metabolism in mitochondria (3). It
was reported previously that binding of pioglitazone stabilizes
the mitoNEET [2Fe-2S] clusters (21) and shifts the redox midpoint potential of the [2Fe-2S] clusters by about 100 mV (26).
Here we found that pioglitazone and its analog NL-1 (36) can
inhibit the electron transfer activity of mitoNEET (Fig. 5) by
forming a unique complex with mitoNEET and FMNH2 that
has an unusual EPR signal at g ⫽ 1.85 (Fig. 6). Based on molecular docking modeling (29, 36), FMN and pioglitazone/NL-1
have distinct binding sites but with significant overlap in
mitoNEET, suggesting that pioglitazone/NL-1 may interfere
with FMNH2 binding in mitoNEET and inhibit the electron
transfer activity of mitoNEET in mitochondria. As mitoNEET
is proposed as a chemotherapeutic target for treating type II
diabetes (4), breast cancer (16, 17), and neurodegenerative diseases (10), a high-throughput screening approach combining
the electron transfer activity assay and EPR measurements of
mitoNEET may help identify new drugs that specifically target
the mitoNEET [2Fe-2S] clusters in mitochondria.

EPR measurements
The X-band EPR spectra were recorded using a Bruker
model ESR-300 spectrometer equipped with an Oxford Instruments 910 continuous flow cryostat. Routine EPR conditions
were as follows: microwave frequency, 9.47 GHz; microwave
power, 10.0 milliwatt; modulation frequency, 100 kHz; modulation amplitude, 1.2 millitesla; temperature, 30 K; receiver
gain, 2 ⫻ 105.
Chemicals
NADH, NADPH, isopropyl ␤-D-1-thiogalactopyranoside,
kanamycin, and ampicillin were purchased from Research
Products International. FMN, FAD, ubiquinone-2, pioglitazone, NL-1, and other chemicals were purchased from Sigma.
The molar extinction coefficients of 6.2 mM⫺1cm⫺1 at 340 nm,
12.5 mM⫺1cm⫺1 at 445 nm, and 11.3 mM⫺1cm⫺1 at 450 nm
were used for measuring the concentration of NADH/NADPH,
FMN, and FAD, respectively (43). The molar extinction coefficient of 14.9 mM⫺1cm⫺1 at 278 nm was used for ubiquinone-2.
Author contributions—Y. W., A. P. L., and H. D. designed, performed, and analyzed the experiments. All authors reviewed the
results and approved the final version of the manuscript.
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